TRIF-mediated TLR3/TLR4 signaling | R-HSA-937061 | 6.47 |
Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 9.81 |
The NLRP3 inflammasome | R-HSA-844456 | 9.4 |
Platelet degranulation | R-HSA-114608 | 6.68 |
G alpha (i) signalling events | R-HSA-418594 | 5.1 |
Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.51 |
Immune System | R-HSA-168256 | 2.37 |
MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.68 |
Peptide ligand-binding receptors | R-HSA-375276 | 5.41 |
MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.73 |
Extracellular matrix organization | R-HSA-1474244 | 4.91 |
RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways | R-HSA-168928 | 6.7 |
Lysosome Vesicle Biogenesis | R-HSA-432720 | 7.85 |
Clathrin derived vesicle budding | R-HSA-421837 | 6.85 |
Disease | R-HSA-1643685 | 3.33 |
ECM proteoglycans | R-HSA-3000178 | 6.75 |
Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.73 |
Platelet activation, signaling and aggregation | R-HSA-76002 | 5.15 |
Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 4.26 |
Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.47 |
Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 6.59 |
Toll-Like Receptors Cascades | R-HSA-168898 | 5.91 |
Amyloids | R-HSA-977225 | 7.37 |
Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 6.11 |
ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 8.28 |
GPCR ligand binding | R-HSA-500792 | 4.19 |
Inflammasomes | R-HSA-622312 | 8.89 |
TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.4 |
Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.56 |
GPCR downstream signaling | R-HSA-388396 | 3.07 |
Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 4.69 |
Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 6.68 |
Innate Immune System | R-HSA-168249 | 3.17 |
Membrane Trafficking | R-HSA-199991 | 5.26 |
TAK1 activates NFkB by phosphorylation and activation of IKKs complex | R-HSA-445989 | 8.08 |
trans-Golgi Network Vesicle Budding | R-HSA-199992 | 6.85 |
RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 8.59 |
Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 6.94 |
DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 9.28 |
MyD88-independent TLR3/TLR4 cascade | R-HSA-166166 | 6.47 |
Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 9.28 |
Vesicle-mediated transport | R-HSA-5653656 | 4.33 |
Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.51 |
Signaling by GPCR | R-HSA-372790 | 2.68 |
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.72 |
Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.73 |
G alpha (q) signalling events | R-HSA-416476 | 5.42 |
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 7.31 |
MyD88:Mal cascade initiated on plasma membrane | R-HSA-166058 | 6.56 |
Activated TLR4 signalling | R-HSA-166054 | 6.27 |
Hemostasis | R-HSA-109582 | 3.98 |
Signal Transduction | R-HSA-162582 | 1.78 |
Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 6.62 |